Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation

被引:8
|
作者
Fukazawa, Kyota [1 ]
Nishida, Seigo [2 ,3 ]
Pretto, Ernesto A., Jr. [4 ]
Vater, Youri [1 ]
Reyes, Jorge D. [5 ]
机构
[1] Univ Washington, Div Transplantat, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA
[2] Univ Miami, Miller Sch Med, Div Liver & Gastrointestinal Transplant, Dept Surg, Miami, FL 33136 USA
[3] Jackson Mem Hosp, Miami, FL 33136 USA
[4] Univ Miami, Miller Sch Med, Div Solid Organ Transplantat, Dept Anesthesiol Perioperat Med & Pain Management, Miami, FL 33136 USA
[5] Univ Washington, Sch Med, Dept Surg, Div Transplantat, Seattle, WA 98195 USA
关键词
Body surface area; Liver transplant; Model for end-stage liver disease; Size mismatch; Survival; PORTAL VENOUS-PRESSURE; CLINICAL-IMPLICATIONS; BACTERIAL TRANSLOCATION; PORTACAVAL-SHUNT; WATER-RETENTION; VEIN PRESSURE; HEPATITIS-C; MELD SCORE; CIRRHOSIS; HYPERPERFUSION;
D O I
10.1002/jhbp.355
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundIn orthotopic liver transplantation (OLT) size-mismatch may cause adverse outcomes. We previously reported on a method to predict donor-recipient size-mismatch using the body surface area index (BSAi). In this study, we hypothesized that graft survival of size-mismatch transplantation deteriorates with higher model for end-stage liver disease (MELD) score at transplantation. MethodsWe evaluated non-parametrically the association of BSAi and MELD with 1-year graft survival with a generalized additive model. For derivation, transplantations performed between 2005 and 2010 were used. The associations were then validated by comparing Kaplan-Meier estimates between patient groups stratified according to estimated risk, using transplantations from 2011-2013. ResultsA total of 30,870 OLT were included in the study with 16,466 in the validation group. The derivation model revealed that graft survival significantly decreased with higher or lower BSAi, and with higher MELD (P < 0.0001). Validation confirmed the correlation of observed graft survival with estimated risk categories. ConclusionsWe found that there is an interactive effect between MELD score and size-mismatch. Also high MELD recipient has a narrower safety margin for size-mismatched graft. The risk calculated from our nonparametric model with MELD and BSAi well predicts outcome in liver transplantation.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 50 条
  • [41] Survival After Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease and Pre-Model for End-Stage Liver Disease Eras and the Independent Impact of Hepatitis C Virus
    Thuluvath, Paul J.
    Maheshwari, Anurag
    Thuluvath, Nimisha P.
    Nguyen, Geoffrey C.
    Segev, Dorry L.
    LIVER TRANSPLANTATION, 2009, 15 (07) : 754 - 762
  • [42] A model to predict survival in patients with End-Stage Liver Disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, WK
    Therneau, TM
    D'Amico, G
    Kosberg, CL
    Dickson, ER
    Kim, WR
    GASTROENTEROLOGY, 2001, 120 (05) : A76 - A77
  • [43] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    HEPATOLOGY, 2001, 33 (02) : 464 - 470
  • [44] Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation
    Carrion, Andres F.
    Khaderi, Saira A.
    Sussman, Norman L.
    LIVER TRANSPLANTATION, 2016, 22 (03) : 279 - 280
  • [45] Is Live Donor Liver Transplantation Appropriate in Recipients with High Model for End Stage Liver Disease Score?
    Chaudhary, Neeraj
    Chaudhary, Abhideep
    Vaudevan, Karisangal Ramaswamy
    TRANSPLANTATION, 2015, 99 : 215 - 216
  • [46] Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation
    Yang, Mengfan
    Khan, Abdul Rehman
    Lu, Di
    Wei, Xuyong
    Shu, Wenzhi
    Xu, Chuanshen
    Pan, Binhua
    Zhou, Zhisheng
    Wang, Rui
    Wei, Qiang
    Cen, Beini
    Cai, Jinzhen
    Zheng, Shusen
    Xu, Xiao
    FRONTIERS IN MEDICINE, 2022, 9
  • [47] Impact of Donor Recipient Gender and Race Mismatch on Graft Outcomes in Patients With End-Stage Liver Disease Undergoing Liver Transplantation
    Zhang, Yefei
    PROGRESS IN TRANSPLANTATION, 2017, 27 (01) : 39 - 47
  • [48] Use of High-Risk Liver Allografts Lowers Survival in Patients with Low Model for End-Stage Liver Disease Scores Impact of the Model for End-Stage Liver Disease allocation policy on the use of high-risk organs for liver transplantation
    Perkins, James D.
    LIVER TRANSPLANTATION, 2009, 15 (02) : 258 - 259
  • [49] Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
    Li, Yan
    Lu, Lungen
    Cai, Xiaobo
    BIOMOLECULES, 2021, 11 (12)
  • [50] Sarcopenia in end-stage liver disease and after liver transplantation
    Leunis, S.
    Vandecruys, M.
    Craenenbroeck, A. H. Van
    Cornelissen, V.
    Bogaerts, S.
    De Smet, S.
    Monbaliu, D.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2023, 86 (02) : 323 - 334